Modern Vaccines Adjuvants Formulation

18-20 May 2016, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size

Day Three

Final Conference Programme | Friday 20th May 2016

SESSION 7:
Vaccine and adjuvant characterization

Session Moderator: Chris Fox (IDRI, Seattle, Washington, USA)

09:00-09:20
‘The use of FACS analysis for detecting antigen interaction with mineral adjuvants’
Laurent Duroux (Brenntag Biosector, Frederikssund, Denmark)

09:20-09:40
‘High precision protein folding analysis in drug discovery and formulation development by nanoDSF’
Teresia Hallström 1, Dennis Breitsprecher 1, Melanie Maschberger 1, Stefanie Hüttl 2, Thomas Müller 2, Stefan Duhr 1 and Philipp Baaske 1 (1 NanoTemper Technologies GmbH, Munich, Germany: 2 Julius-von-Sachs Institute, University Wuerzburg, Wuerzburg, Germany)

09:40-10:00
‘Development and characterization of the novel adjuvant CAF09b’
Ida Svahn Rasmussen (Statens Serum Institut, Copenhagen, Denmark)

10.00-10.20
‘Characteristics of adjuvants designed for therapeutic cancer vaccines’

Aude Puget (SEPPIC, Paris, France)

10:20-10.40
Wrap-up by Session Moderator

10:40-11:00
Coffee Break and Poster Breakdown

SESSION 8:
VACCINES/ADJUVANTS & DELIVERY

Session Moderator: Gideon Kersten (Intravacc, Bilthoven, The Netherlands)

11:00-11:30
‘Implications for the quality of cellular and humoral responses after antigen delivery on nanoparticles and polymersomes’
Marcela Rincon-Restrepo, Aaron Mayer, Clara Galan-Navarro, Sylvie Hauert, Stefan Kunz, Sachiko Hirosue, Jeffrey Hubbelland and Melody Swartz (Ecole Polytechnique Fédéralede Lausanne/University of Lausanne, Lausanne, Switzerland and University of Chicago, Chicago, Michigan, USA)

11:30-11:50
‘Lipovaxin, nano-particulate chelating lipid-based immunostimulatory particles for improved recombinant vaccine formulations’
Jason D. Price, Nicola C. MacLennan, Anthony D. Rusden, Katharine M. Gosling and Ines I.C. Atmosukarto (Lipotek Pty Ltd, New Acton, Canberra, Australia)

11:50-12:10
‘Targeting of cross presenting dendritic cells in the lymphoid tissue: The importance of choosing the correct administration route’
Signe T. Schmidt (Statens Serum Institut, Copenhagen, Denmark)

12:10-12:30
‘Aluminum nanoparticle adjuvant for intradermal vaccines’
Jean Haensler (Sanofi Pasteur, Lyon, France)

12:30-12:50
‘An anti-Abeta liposome vaccine shows efficacy in a Down Syndrome (DS) mouse model’
Emma Fiorini (AC Immune SA, Lausanne, Switzerland)

12:50-13:00
Wrap-up by Session Moderator

13:00-14:00
Lunch Break & Poster Breakdown

SESSION 9:
LATEBREAKER PRESENTATIONS

Moderator: To be confirmed

14.00-14.30
‘The role of electrostatic interactions in vaccine processing, stability and post-injection phenomena’
Henryk Mach, Pat Ahl, David Thiriot, Erin-Green Trexler, Bei Wang and Jeffrey Blue (Merck Research Laboratories, West Point, Pennsylvania, USA)

14.30-14.50
‘Nanoformulation of synergistic TLR ligands to enhance protective immunity against Entamoeba histolytica’
Mayuresh M Abhyankar 1, Zannatun Noor 1, Lisa Barroso 2, David Lyerly 2, Christopher B Fox 3 and William A Petri, Jr. 1 (1 University of Virginia, Charlottesville, Virginia, USA; 2 TechLab, Inc., Blacksburg, Virginia, USA; 3 Infectious Disease Research Institute, Seattle, Washington, USA)

14.50-15.10
‘Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses’
Amir I. Tukhvatulin,  Alina S. Dzharullaeva, Natalia M. Tukhvatulina, Inna V. Dolzhikova, Boris S. Naroditsky, Alexander L. Gintsburg and Denis Y. Logunov (N. F. Gamaleya Research Center for Epidemiology and Microbiology, Moscow, Russia)

15.10-15.20
MVAF 2016 Summary & Conference Close

* This final programme is correct at the time of printing. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the final conference programme.

 

MVAF 2016 Delegates

Login details will be supplied after you have registered for the event.


MVAF 2016 Sponsors

  • NanoTemper Technologies
  • Mucosis
  • Aldevron
  • Inovio
  • hVIVO
  • Pfizer
  • IntraVacc
  • Seppic
  • CureVac
  • Vaxart
  • Brenntag
  • Sanofi Pasteur
  • Bioaster
  • DNAvaccine.com
  • EVI
  • NatureGeneTherapy.com
  • IDRI

MVAF 2016 Downloads

MVAF 2016 Leaflet

MVAF 2016 Mailing List

Name
E-mail Address
What is 3+2-1?